Tumour markers CEA, NSE, and CYFRA 21-1 are widely used for lung cancer screening and diagnosis [9-11,15]. This case demonstrated the combination of three clinical conditions diagnosed in one patient, including complicated silicosis associated with sarcoidosis and an elevated blood concentration of the NSE biomarker. This evidence concerns the gene ENO2 and lung cancer.